Mangoceuticals (MGRX) Cash from Investing Activities (2023)
Mangoceuticals' (MGRX) quarterly Cash from Investing Activities came in at -$3519.0 in Q1 2023.
Mangoceuticals (MGRX) Cash from Investing Activities (2023) Analysis & Trends
Mangoceuticals has disclosed Cash from Investing Activities across 1 years of filings, most recently posting -$3519.0 for Q1 2023.
- Cash from Investing Activities for Q1 2023 came in at -$3519.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was -$3519.0 (changed N/A YoY), and the FY2024 annual result was $65000.0, up 1947.12% from the prior year.
- Cash from Investing Activities came in at -$3519.0 for Q1 2023 at Mangoceuticals.
- In the past five years, Cash from Investing Activities ranged from a high of -$3519.0 in Q1 2023 to a low of -$3519.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | -388.71 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 747.39 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | -13.90 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 48.08 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -1.31 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 137.98 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | -112.49 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -26,000.00 |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | -15.87 Mn |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -3,519.00 |
| Mar 31, 2023 | -3,519.00 |